News - Grifols

Filter

Current filters:

Grifols

Popular Filters

Novartis sells blood transfusion diagnostics unit to Grifols for $1.675 billion

Novartis sells blood transfusion diagnostics unit to Grifols for $1.675 billion

11-11-2013

Swiss drug major Novartis says it is divesting its blood transfusion diagnostics unit to Spain’s Grifols…

GrifolsMergers & AcquisitionsNovartisPharmaceutical

Grifols gains global rights to Aradigm's Pulmaquin

23-05-2013

Spanish drugmaker Grifols (GRLS: MC) has signed an exclusive, worldwide license for USA-based Aradigm's…

Antibiotics and Infectious diseasesAradigmCiprofloxacinGrifolsLicensingMergers & AcquisitionsPharmaceuticalPulmaquinRespiratory and Pulmonary

The solution for Spanish pharma companies lies abroad

13-03-2013

The pressure on the prices of medicines by Spanish government has seen the pharmaceutical market in Spain…

AlmirallEuropeFinancialGrifolsPharmaceuticalPricingRegulationZeltia

Grifols acquires 40% of Spanish biotech firm VCN Bioscience

16-07-2012

Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer,…

BiotechnologyGrifolsMergers & AcquisitionsOncologyVCN Bioscience

Grifols acquires 51% stake in Araclon Biotech

19-03-2012

Spanish plasma products specialist Grifols (MCE: GRF) has acquired 51% of the equity of Zaragoza, Spain-based…

Araclon BiotechBiotechnologyGrifolsMergers & AcquisitionsNeurologicalPharmaceuticalVaccines

Executive appointments at Grifols and Actelion

08-06-2011

Following the recent acquisition of USA-based Talecris Biotherapeutics (The Pharma Letter June 2), Spanish…

ActelionBiotechnologyGrifolsManagementPharmaceutical

Grifols must divest assets to complete acquisition of Talecris, says USA’s FTC

02-06-2011

The USA’s Federal Trade Commission will require Spanish firm Grifols (GRLS: MC), a manufacturer…

GrifolsMergers & AcquisitionsPharmaceuticalTalecris

Grifols closer to Talecris acquisition, but must sell assets

03-05-2011

Spanish health care group Grifols (GRLS: MC) and acquisition target Talecris Biotherapeutics (Nasdaq:…

GrifolsMergers & AcquisitionsPharmaceuticalTalecris

Back to top